IBS Treatment Market Definition
Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both. Only a small number of people with IBS have severe signs and symptoms. Some people can control their symptoms by managing diet, lifestyle and stress. More-severe symptoms can be treated with medication and counseling. Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle are the key drivers of the IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region.
The market study is broken down by Type (IBS-D, IBS-C and IBS-M), by Application (Hospitals, Clinics and Research Laboratories) and major geographies with country level splits.
The market is highly fragmented with the presence of various players in the market. Some of the key strategies followed by the players operating in the market were innovation, product development, acquisition, and expansion. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global IBS Treatment market throughout the predicted period.
Novartis AG (Switzerland), Abbott Laboratories (United States), Synergy Pharmaceuticals, Inc. (United States), Allergan Plc (Ireland), Sucampo Pharmaceuticals (United States), Ironwood Pharmaceuticals, Inc. (United States), Astellas Pharma Inc. (Japan), Valeant Pharmaceuticals (Canada), Ardelyx, Inc. (United States) and Sebela Pharmaceuticals (Ireland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Probi (Sweden), Alfasigma USA, Inc. (Italy), RedHill Biopharma Ltd. (Israel), AstraZeneca (United Kingdom), Ipsen (France), Takeda Pharmaceutical Company Ltd (Japan) and Synthetic Biologics, Inc. (United States).
AdvanceMarketAnalytics has segmented the market of Global IBS Treatment market by Type, Application and Region.
On the basis of geography, the market of IBS Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug, the sub-segment i.e. Lubiprostone will boost the IBS Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product, the sub-segment i.e. Xifaxan will boost the IBS Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing adoption of inorganic strategies by manufacturer
- Increase prevalence of irritable bowel syndrome among the population
- Increase in research and development of new therapeutic products for the treatments of IBS
- Increasing investments and funding in the field of life science
- Side effects associated with various drugs taken in curing IBS
Key Target AudienceAcademic research institute, Pharmaceuticals companies, Biotechnology companies, Contract research organization and Market research and consulting firms
About ApproachThe research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase